Dupont Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-520
| Closed | -$108K | – | 1124 |
|
|
2022
Q4 | $108K | Buy |
520
+97
| +23% | +$21.3K | 0.01% | 921 |
|
|
2022
Q3 | $92K | Buy |
+423
| New | +$96.3K | 0.01% | 1070 |
|
|
2022
Q2 | – | Sell |
-688
| Closed | -$167K | – | 1737 |
|
|
2022
Q1 | $167K | Sell |
688
-32
| -4% | -$7.74K | 0.01% | 1125 |
|
|
2021
Q4 | $188K | Sell |
720
-425
| -37% | -$110K | 0.01% | 1142 |
|
|
2021
Q3 | $302K | Buy |
+1,145
| New | +$313K | 0.01% | 1068 |
|
|
2021
Q2 | – | Sell |
-3,043
| Closed | -$590K | – | 1820 |
|
|
2021
Q1 | $590K | Sell |
3,043
-936
| -24% | -$188K | 0.01% | 843 |
|
|
2020
Q4 | $846K | Sell |
3,979
-2,539
| -39% | -$506K | 0.02% | 623 |
|
|
2020
Q3 | $1.12M | Buy |
6,518
+2,131
| +49% | +$394K | 0.02% | 466 |
|
|
2020
Q2 | $842K | Sell |
4,387
-8,830
| -67% | -$1.44M | 0.02% | 583 |
|
|
2020
Q1 | $1.95M | Buy |
13,217
+11,051
| +510% | +$1.76M | 0.05% | 302 |
|
|
2019
Q4 | $336K | Buy |
2,166
+500
| +30% | +$72.1K | 0.01% | 1030 |
|
|
2019
Q3 | $225K | Sell |
1,666
-900
| -35% | -$118K | 0.01% | 1075 |
|
|
2019
Q2 | $313K | Sell |
2,566
-10,098
| -80% | -$1.12M | 0.01% | 987 |
|
|
2019
Q1 | $1.32M | Sell |
12,664
-16,289
| -56% | -$1.68M | 0.03% | 476 |
|
|
2018
Q4 | $3.3M | Buy |
28,953
+11,383
| +65% | +$1.22M | 0.08% | 241 |
|
|
2018
Q3 | $2.03M | Buy |
17,570
+15,134
| +621% | +$1.66M | 0.04% | 379 |
|
|
2018
Q2 | $252K | Buy |
2,436
+1,206
| +98% | +$122K | 0.01% | 837 |
|
|
2018
Q1 | $121K | Buy |
+1,230
| New | +$116K | ﹤0.01% | 866 |
|
|
2017
Q3 | – | Sell |
-735
| Closed | -$57K | – | 980 |
|
|
2017
Q2 | $57K | Sell |
735
-365
| -33% | -$26.1K | ﹤0.01% | 899 |
|
|
2017
Q1 | $79K | Buy |
+1,100
| New | +$76K | ﹤0.01% | 825 |
|
|
2016
Q4 | – | Sell |
-1,535
| Closed | -$99K | – | 863 |
|
|
2016
Q3 | $99K | Sell |
1,535
-63,927
| -98% | -$4.26M | ﹤0.01% | 644 |
|
|
2016
Q2 | $4.14M | Sell |
65,462
-4,138
| -6% | -$244K | 0.09% | 194 |
|
|
2016
Q1 | $4.02M | Sell |
69,600
-3,400
| -5% | -$192K | 0.09% | 210 |
|
|
2015
Q4 | $3.92M | Buy |
73,000
+4,700
| +7% | +$265K | 0.09% | 210 |
|
|
2015
Q3 | $3.48M | Buy |
68,300
+12,930
| +23% | +$696K | 0.09% | 234 |
|
|
2015
Q2 | $3.12M | Hold |
55,370
| – | – | 0.07% | 267 |
|
|
2015
Q1 | $3.97M | Buy |
+55,370
| New | +$3.6M | 0.08% | 250 |
|
|
2014
Q3 | – | Sell |
-1,630
| Closed | -$83K | – | 652 |
|
|
2014
Q2 | $83K | Sell |
1,630
-154,160
| -99% | -$7.64M | ﹤0.01% | 632 |
|
|
2014
Q1 | $6.96M | Buy |
155,790
+93,924
| +152% | +$4.22M | 0.11% | 134 |
|
|
2013
Q4 | $2.91M | Buy |
+61,866
| New | +$3.13M | 0.05% | 276 |
|
Other funds holding RMD
Dupont Capital Management's RMD Position: Q1 2023 in Review
Dupont Capital Management sold out of ResMed (RMD) in Q1 2023, closing a stake of 520 shares — an estimated $108K sold.
Dupont Capital Management first reported a position in RMD in Q4 2013 and held it in 30 quarters. The position peaked at $6.96M in Q1 2014. 676 funds tracked by Wall St. Rank hold RMD as of Q1 2023.
- Dupont Capital Management reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
- Dupont Capital Management sold 520 ResMed shares in Q1 2023, an estimated $108K.
- Dupont Capital Management first reported a position in ResMed in Q4 2013 and held it in 30 quarters.
- Dupont Capital Management's ResMed position peaked at $6.96M in Q1 2014.
- 676 funds tracked by Wall St. Rank held ResMed as of Q1 2023.
Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.